Cyto stock forecast Webull offers Altamira Therapeutics Ltd stock information, including NASDAQ: CYTO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYTO stock news, and many more online research tools to help you make informed decisions. 4m. 48, a high forecast of $0. 43 and our data indicates that the asset price has been in a downtrend since 2014-Aug-06. Specifically, they have bought $0. 41% relative to our estimate of its Fair Value price of $1. F's market cap by their current book value. 91% decrease. 39%; Real-time U. CYTO Stock Earnings: Altamira Therapeutics Reported Results for H1 2023 (InvestorPlace)-13. 39. 35 - 5. 469. Complete Altamira Therapeutics Ltd. Read more about CytoDyn's insider trading history. 50 to $50. 37. 0. 0. 13% upside) Analyst Consensus: Buy. See CYTO stock price and Buy/Sell Altamira Therapeutics Ltd. Dec 18, 2024. . Percentage Held by Insiders. TSXV:CYTO Stock Report. 02% and hit $ 0. stock price history, forecast, predictions, news and dividends - Altamira Therapeutics Ltd 1-877-778-8358 Functions Templates Pricing Blog Altamira Therapeutics Ltd Stock forecast & analyst price target predictions, earnings, revenue ,EPS predictions, upgrades and downgrades. 95% increase from the current price of $0. 41, so CYTO's price volatility has been higher than the market average. Find the latest CytoDyn Inc. 68% compared to the previous week, the month change is a −6. Altamira Therapeutics's earnings are forecast to decline at 5. 19 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety Dec 9, 2024 · CYTO Buy or Sell today, predictions 2025, Altamira Therapeutics price target today, Technical and Fundamental analysis CYTO stock forecast, quote, news & analysis 4 days ago · A rising stock on above average volume is typically a bullish sign whereas a declining stock on above average volume is typically bearish. The highest analyst price target is $563. Altamira Therapeutics stock analysis 2024. 58% compared to the previous week, the month change is a −3. 's expected market performance. has showed a −88. Apr 12, 2024 · The chart below shows the historical price of Altamira Therapeutics stock and a prediction chart for the next year. 76% on 11/27/24 and has lost a total of -6. com - Financial Markets Worldwide Open in App Nov 18, 2024 · The chart below shows the historical price of Altamira Therapeutics stock and a prediction chart for the next year. 28% in the last 52 weeks. Dec 14, 2024 Stock Style Box Small Value. stock was issued. About the Altamira Therapeutics Ltd Stock forecast. 12% increase from the last price of $0. 55. 26. The average stock forecast for Altamira Therapeutics Ltd (CYTO) is 5. Markets; Forecast . CYTO is trading in the range of $0. 57 USD. 9% per annum. 32m: Market Cap: US$1. CYTO stock has fallen by −9. On average, 1 Wall Street analyst forecast CYTO's earnings for 2024 to be -$7,076,889, with the lowest CYTO earnings forecast at -$7,076,889, and the highest CYTO earnings forecast at -$7,076,889. (CYTO) stock news and headlines to help you in your trading and investing decisions. 00 in company stock. $5. Altamira Therapeutics Ltd. The Altamira Therapeutics Ltd (CYTO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $544. Insufficient data to determine if CYTO's revenue is forecast to grow faster than the Canadian market. As they say, 'price follows volume'. 337927). 87% gain compared to the current price. 🚀 Enjoy a 7-Day Free Trial Thru Oct 10, 2024! Sign Up Dec 13, 2024 · According to one analyst, the rating for GDTC stock is "Buy" and the 12-month stock price forecast is $5. (CYTO) stock. The company develops and supplies OligoPhore/SemaPhore platforms, which are peptide-based nanoparticle technologies for ribonucleic acid delivery to extrahepatic tissues. 2 days ago · In the past three months, Cytokinetics insiders have sold more of their company's stock than they have bought. Altamira Therapeutics Ltd Stock Price Forecast, "CYTO" Predictons for2025. Holders of the company’s shares will want to keep an eye on it in the near future to learn its fate. Find out the current price target and stock forecast for Altamira Therapeutics (CYTO) Altamira Therapeutics (CYTO) (Delayed Data from NSDQ) $0. 27% from a day low at $50. 392%. Discover historical prices for CYTO stock on Yahoo Finance. Analysis of Altamira Therapeutics Market Facilitation Index, Market Facilitation Index is simply a difference between period high and low prices divided by period trading volume. 's earnings in 2024 is -$3,279,951. Share your ideas and get valuable insights from the community of like minded traders and investors Nov 23, 2024 · CYTO ($0. Total Number of Employees 12. (CYDY) stock quote, history, news and other vital information to help you with your stock trading and investing. 73% fall, over the last year Altamira Therapeutics Ltd. 20, representing a +115934. 22%. 55%) Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. View real-time CYTO stock price and news, along with industry-best analysis. 9% per annum while its annual revenue is expected to grow at 149% per year. 5 days ago · About CYTO. Website Altamira Therapeutics. CYTO stock quote prices, financial information, real-time forecasts, and company news from CNN. 98% in the past 2 days. 1 day ago · Summary of share price highs, lows and changes for Altamira Therapeutics; Historical stock prices; Current Share Price: US$0. The Cytokinetics stock price gained 0. As of 2024-Nov-30 current price of CYTO is $0. stock information by Barron's. Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 8. Read more about Cytokinetics' insider trading history. View All companies ` 11:36 AM EST 11/21/24 $ 0. Sponsored ADR RDHL stock quote prices, financial information, real-time forecasts, and company news from CNN. Track CytoDyn Inc (CYDY) Stock Price, Quote, latest community messages, chart, news and other stock related information. What is CYTO. S. Price Target. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Market Cap: CA$15. analyst estimates, including CYTO earnings per share estimates and analyst recommendations. The 20 day average Nov 29, 2024 · Altamira Therapeutics Ltd. In the next week, the price of CYTO is expected to decrease by -0. 425 USD-0. (CYTO) stock quote, history, news and other vital information to help you with your stock trading and investing. stock highest and lowest prices ever? Nov 27, 2023 · It makes sense that CYTO stock would be down as investors react to news of a potential delisting. 77% fall, over the last year Altamira Therapeutics Ltd. Forecast target price for 12-27-2024: $ 0. Crypto Forecasts; Top 5 Crypto forecasts; Tether Usdt forecast; Bitcoin View RedHill Biopharma Ltd. Get the latest Altamira Therapeutics Ltd CYTO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 3 days ago · CYTO is trading within a range we consider fairly valued. Add to watchlist. The stock price has decreased by -94. 464, which would represent a 0. View CYTO current price, quote, financial & revenue summaries, forecast, earnings transcripts, and news. stock quotes reflect trades reported through Nasdaq Aug 15, 2024 · CYTO Stock Predictions, Articles, and Altamira Therapeutics Ltd News Why Is Altamira Therapeutics (CYTO) Stock Down 8% Today? By William White , InvestorPlace Writer Nov 27, 2023 Sep 24, 2024 · Stock Price Statistics. Nov 29, 2024 · Altamira Therapeutics Ltd. EPS is expected to grow by 78. 31. Fair Value $0. 54% of the stock of CytoDyn is held by insiders. 135000005364418. stock highest and lowest prices ever? Dec 13, 2024 · View Altamira Therapeutics Ltd CYTO investment & stock information. CYTO analyst stock forecast, price target, and recommendation trends with in-depth The Altamira Therapeutics Ltd. 54, and a low forecast of $0. 00 in company stock and sold $3,923,463. For CytoDyn stock forecast 2031, 12 predictions are offered for each month of 2031 with average CytoDyn stock forecast of $0. has showed a −90. 12: 52 Week High: US$3. 0990% on the last trading day (Tuesday, 10th Dec 2024), rising from $50. operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia. Only 3. View Altamira Therapeutics Ltd. 63 in the past 30 days. 42) is undervalued by 64. The range of stock forecasts for CYTO is 5. What are Altamira Therapeutics Ltd. 0149-3. 40% of the stock of Cytokinetics is held by insiders. The best long-term & short-term Altamira Therapeutics share price prognosis for 2023, 2024, 2025 2 days ago · Altamira Therapeutics Stock (NASDAQ: CYTO) stock price, news, charts, stock research, profile. Investing. 463924. Find the latest Altamira Therapeutics Ltd. 65. Dec 13, 2024 · According to one analyst, the rating for GDTC stock is "Buy" and the 12-month stock price forecast is $5. CYTO Stock Analysis CYTO is down -4. View daily, weekly or monthly format back to when Altamira Therapeutics Ltd. For convenience, prices are divided by color. 77,395-0. : Nasdaq) search. During the last trading day the stock fluctuated 2. This is calculated by dividing CYTO. Get the latest Altamira Therapeutics Ltd (CYTO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Altamira Therapeutics Market Facilitation Index. 12 to a day high of $51. Only 0. 06x: Book: US$6. F. Nov 18, 2024 · The chart below shows the historical price of Altamira Therapeutics stock and a prediction chart for the next year. Find the latest Altamira Therapeutics Ltd (CYTO) stock forecast, 12-month price target, predictions and analyst recommendations. Discuss news and analysts' price predictions with the investor community. 21%. Get the latest Altamira Therapeutics Ltd. Price $0. Nov 30, 2023 · View Altamira Therapeutics Ltd (CYTO) stock price today, market news, streaming charts, forecasts and financial information from FX Empire. Altamira Therapeutics Stock Forecast, CYTO stock price prediction. May 5, 2021 · The average CytoDyn stock forecast 2030 represents a 173. Dec-11-23 08:00AM Altamira Therapeutics Provides Investor and Business The above table shows the Price to Book ratio for CYTO. View Altamira Therapeutics Ltd. Percentage Held by Institutions. A high-level overview of Altamira Therapeutics Ltd. Detailed values for the CYTO stock price can be found in the table below. Track Altamira Therapeutics Ltd (CYTO) Stock Price, Quote, latest community messages, chart, news and other stock related information. 03, and the lowest is $525. 41 USD. stock forecast for tomorrow is $ 0. 2 days ago · In the past three months, CytoDyn insiders have not sold or bought any company stock. Only 5. 06% of the stock of CytoDyn is held by institutions. Share your ideas and get valuable insights from the community of like minded traders and investors CYTO stock has fallen by −12. Utilize in-depth analyses and data insights for strategic investing. Share your ideas and get valuable insights from the community of like minded traders and investors Nov 24, 2024 · CYTO: AI Stock Analysis of Altamira Therapeutics Ltd, including Stock Price, Stock Chart, Technical, Fundamental, Sentiment Analysis and more. 41. Discover monthly forecasts for (CYTO) to navigate Altamira Therapeutics Ltd. F's PB Ratio? PB Ratio: 0. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. 0 (84. 02m Altamira Therapeutics Ltd. This price target corresponds to an upside of 1,157. The beta is 2. 27% decrease. Is CYTO stock going to rise? Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTO is experiencing buying pressure, which is a positive indicator for future bullish movement. Altamira Therapeutics (NASDAQ:CYTO) stock soared 44% in midday trading Monday after the biotech company announced a collaboration with Univercells for the potential development of mRNA vaccines CYTO - Stock evaluation, ranks. Nov 18, 2024 · Altamira Therapeutics Stock Forecast 12-27-2024. 60: 52 Week Low Dec 10, 2024 · Sell candidate since Dec 04, 2024 Gain 0. 2 days ago · CytoDyn Stock (OTC: CYDY) stock price, news, charts, stock research, profile. 40 - $0. 02 (-4. CYTO (U. (CYTO) stock forecast and price target. 97%. omydcwl bmr mlrdxnd uqzas ipi kndyyba nkkxuy kdevy xjx qhsrgnc